These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19275648)

  • 1. The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
    César LA; Gowdak LH; Mansur AP
    Curr Pharm Des; 2009; 15(8):841-9. PubMed ID: 19275648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of metabolically active drugs in the management of ischemic heart disease.
    Schofield RS; Hill JA
    Am J Cardiovasc Drugs; 2001; 1(1):23-35. PubMed ID: 14728049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic heart disease: metabolic approaches to management.
    Pauly DF; Pepine CJ
    Clin Cardiol; 2004 Aug; 27(8):439-41. PubMed ID: 15346837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic modulators for chronic cardiac ischemia.
    Parang P; Singh B; Arora R
    J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):217-23. PubMed ID: 16382258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.
    Rupp H; Zarain-Herzberg A; Maisch B
    Herz; 2002 Nov; 27(7):621-36. PubMed ID: 12439634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimetazidine for stable angina.
    Ciapponi A; Pizarro R; Harrison J
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003614. PubMed ID: 16235330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimetazidine for stable angina pectoris.
    Cross HR
    Expert Opin Pharmacother; 2001 May; 2(5):857-75. PubMed ID: 11336628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WITHDRAWN: Trimetazidine for stable angina.
    Ciapponi A; Pizarro R; Harrison J
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD003614. PubMed ID: 28319269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis.
    Savarese G; Rosano G; D'Amore C; Musella F; Della Ratta GL; Pellegrino AM; Formisano T; Vitagliano A; Cirillo A; Cice G; Fimiani L; del Guercio L; Trimarco B; Perrone-Filardi P
    Int J Cardiol; 2013 Nov; 169(4):262-70. PubMed ID: 24063912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trimetazidine in pectoris patients older than 65 years with stable angina].
    Syrkin AL; Lepakhin VK; Fitilev SB; Ivanova EV; Titarova IuIu; Levin AM
    Kardiologiia; 2002; 42(6):24-31. PubMed ID: 12494126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence.
    Ambrosio G; Tamargo J; Grant PJ
    Diab Vasc Dis Res; 2016 Mar; 13(2):98-112. PubMed ID: 26873904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic therapeutics in angina pectoris: history revisited with perhexiline.
    Inglis S; Stewart S
    Eur J Cardiovasc Nurs; 2006 Jun; 5(2):175-84. PubMed ID: 16469541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic angina: new medical options for treatment.
    McCullough PA
    Rev Cardiovasc Med; 2005; 6(3):152-61. PubMed ID: 16195688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
    Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV
    Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimetazidine to reverse ischemia in patients with class I or II angina: a randomized, double-blind, placebo-controlled dobutamine-atropine stress echocardiography study.
    Cesar LA; Mathias W; Armaganijan D; Gimenez V; Jallad S; Del Monaco MI; Bicudo L; Meneguin S; Gomes EP; Brasil CK; Ramires JF
    Coron Artery Dis; 2007 Jun; 18(4):259-63. PubMed ID: 17496489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials.
    Peng S; Zhao M; Wan J; Fang Q; Fang D; Li K
    Int J Cardiol; 2014 Dec; 177(3):780-5. PubMed ID: 25466565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)].
    Chaloupka V
    Vnitr Lek; 2006 Jun; 52(6):609-14. PubMed ID: 16871765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New agents for the therapy of angina pectoris].
    Meinertz T; Köster R
    Internist (Berl); 2011 Jul; 52(7):894-6, 898-900. PubMed ID: 21713611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.